【摘 要】
：
Smart nanoparticles (NPs) that respond to external stimulations, including light, hyperthermia,reduction/oxidation and ultrasound have been developing to achieve optimal drug release in tumor tissues.
【机 构】
：
Department of Chemistry, Guangdong Medical College, Dongguan 523808, PR China;Guangdong Key Laborato
【出 处】
：
纳米药物及纳米生物技术国际学术大会暨中国药学会纳米药物专业委员会成立大会
论文部分内容阅读
Smart nanoparticles (NPs) that respond to external stimulations, including light, hyperthermia,reduction/oxidation and ultrasound have been developing to achieve optimal drug release in tumor tissues.[1, 2] However, applying these smart NPs to attain high antitumor performance is hampered by limited drug carriers and inefficient spatiotemporal control.
其他文献
目的:探讨晶状体悬韧带脆弱条件下的白内障劈核方式,比较非水分离原位劈核技术和水分离拦截劈核技术的安全性和效果.方法:回顾分析悬韧带脆弱的的白内障患者120眼,非水分离原位劈核组72眼,水分离拦截劈核组48眼.结果:后囊破裂+悬韧带断裂者:非水分离原位劈核组为5只眼,水分离拦截劈核组9只眼,两组比较差异有统计学意义;术后矫正视力提高者:非水分离原位劈核组为69只眼,水分离拦截劈核组40只眼,两组比较
目的：探讨改良的白内障超声乳化人工晶体植入联合囊袋张力环治疗大范围晶状体半脱位的临床效果及其安全性。方法：对15例(15只眼)晶状体半脱位(脱位范围大于180度范围以上)的白内障患者行超声乳化白内障吸除术,术中晶状体前囊膜环形撕囊后,将张力环植入囊袋内,常规超声乳化和皮质清除后,将人工晶体植入睫状沟。结果：1、术中对15例(15只眼)均顺利完成CCC-张力环囊袋内植入-Phaco-IOI植入睫状沟
Bacterial and viral DNA containing unmethylated CpG motifs stimulate mammalian innate immune system [1].This process is mediated by the activation of TLR 9, a member of Toll-like receptor family.
Recently, a large number micro-or nano-scale beam arrays have been made using different techniques as a result of the extensive effort on micro-and nano-technologies [1-5].These new structures have th
Content Paclitaxel has been approved for treatment of a variety of carcinomas, including ovarian cancer, breast cancer and non-small-cell lung cancer.However, its application is limited because of the
The combination of chemotherapeutic agents with gene therapy offers a great chance for cancer treatment.In this work, quantum dots-viruses conjugated by click chemistry were developed.
Radiotherapy along with surgery and chemotherapy are the major therapeutic strategies for cancer treatment.The central goal of radiotherapy is to deliver a therapeutic dose to the tumor as much as pos
Doxil(R) (doxorubicin-carrying liposomes) is the first FDA-approved nanomedicine which has been successfully applied to treat several kinds of cancer.
A novel schiff-base conjugated prodrug based on vitamin E TPGS and doxorubicin (TPGS-schiff-DOX) was synthesized for overcoming drug resistance in cancer cells[1].It can be quickly cleaved after endoc
Red blood cells (RBCs), the "innate carriers" in our blood vessels, are gifted with many unique advantages in drug transportation over synthetic drug delivery systems (DDSs).Herein,we develop a tumor